產(chǎn)品詳情
簡單介紹：
Anti-Mannosidase II抗體產(chǎn)品質量穩(wěn)定，實驗效果明顯，貨期快，價格優(yōu)惠，歡迎垂詢訂購！我公司長期供應**組化抗體、WB抗體、**組化試劑盒和抗體試驗所需全部相關試劑、熒光標記抗體、單克隆抗體、多克隆抗體、各種標記的二抗IgG/IgM/IgD/IgA等科研實驗抗體。Anti-Mannosidase II抗體用于**組化實驗,WB實驗,相應的標記抗體有HRP標記抗體,FITC標記,BIO等。
詳情介紹：
Rabbit Anti-Mannosidase II
Cat. Number:
Anti-Mannosidase II抗體KL-18655R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
This gene encodes a glycosyl hydrolase that localizes to the Golgi and catalyzes the final hydrolytic step in the asparagine-linked Anti-Mannosidase II抗體oligosaccharide (N-glycan) maturation pathway. Mutations in the mouse homolog of this gene have been shown to cause a systemic autoimmune disease similar to human systemic lupus erythematosus. [provided by RefSeq, Dec 2013]
Also known as:
3-1; 6-alpha-mannosidase; Alpha mannosidase 2; alpha Mannosidase II; alpha Mannosidase II; Alpha-mannosidase 2; AMAN II; Anti-Mannosidase II抗體Golgi alpha mannosidase II; Golgi alpha-mannosidase II; Golgi integral membrane protein 7; GOLIM7; MA2A1_HUMAN; MAN II; MAN2A1; MANA 2; MANA2; MANII; Mann II; Mann II; Mannosidase alpha class 2A member 1; Mannosidase Two; Mannosidase Two; Mannosidase, alpha type II; Mannosidase, alpha, II; Mannosyl oligosaccharide 1 3 1 6 alpha mannosidase; Mannosyl oligosaccharide 1,3 1,6 alpha mannosidase; Mannosyl oligosaccharide 13 16 alpha mannosidase; Mannosyl-oligosaccharide 1.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, .
●
Immunogen: KLH conjugatedAnti-Mannosidase II抗體 synthetic peptide derived from human Mannosidase II.
●
Predicted Molecular Weight: 131kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications. Anti-Mannosidase II抗體
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications. Anti-Mannosidase II抗體
Optimal working dilutions must be determined by the end user.
